NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7626Listed tickers in the SEC universe 4350Issuers with current reporting periods 1430Issuers with both EPS and ROE metrics 2026-11-06Fundamentals evaluated as of

Example screens

ListCharts
Period 1M3M6M1Y5YMAX
Drawing LineCandles
Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

4350 companies match

Showing 3051–3100 of 4350 · page 62/87

Per page 2550100

Companies with a published price series: 4338 of 4350 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-11-06

All screened companies Only companies with price history
MAS NYSE

MASCO CORP /DE/

68.85 +23.94% 5Y
Combined rank
—
EPS acceleration
5.0 pp
ROE
—
MASS NASDAQ

908 Devices Inc.

11.25 -53.12% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-27.3%
MAT NASDAQ

MATTEL INC /DE/

15.42 -27.30% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
21.4%
MAX NYSE

MediaAlpha, Inc.

14.75 -4.35% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
210.5%
MBI NYSE

MBIA INC

4.46 -62.07% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
MBIO NASDAQ

MUSTANG BIO, INC.

0.40 -99.97% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-40.2%
MBLY NASDAQ

Mobileye Global Inc.

5.96 -77.41% 5Y

history starts Oct 2022

Combined rank
—
EPS acceleration
—
ROE
-49.0%
MBUU NASDAQ

MALIBU BOATS, INC.

23.81 -65.73% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
0.3%
MBX NASDAQ

MBX Biosciences, Inc.

55.87 +115.05% 5Y

history starts Sep 2024

Combined rank
—
EPS acceleration
—
ROE
-25.5%
MC NYSE

Moelis & Co

58.59 -4.44% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
MCD NYSE

MCDONALDS CORP

258.12 +5.53% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
-1.2 pp
ROE
—
MCHX NASDAQ

MARCHEX INC

1.44 -42.63% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
MCK NYSE

MCKESSON CORP

994.58 +358.84% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
34.6 pp
ROE
—
MCS NYSE

MARCUS CORP

26.55 +51.97% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
5.2%
MDAI NASDAQ

Spectral AI, Inc.

1.53 -84.53% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
—
MDB NASDAQ

MongoDB, Inc.

352.96 -29.14% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
2.0%
MDCX NASDAQ

Medicus Pharma Ltd.

1.88 -98.61% 5Y

history starts Nov 2024

Combined rank
—
EPS acceleration
—
ROE
—
MDLN NASDAQ

Medline Inc.

32.12 -21.66% 5Y

history starts Dec 2025

Combined rank
—
EPS acceleration
—
ROE
—
MDT NYSE

Medtronic plc

96.54 -9.52% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
10.4%
MED NYSE

MEDIFAST INC

12.15 -94.09% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-22.7%
MEDS NASDAQ

DataMeds AI, Inc.

1.92 -98.58% 5Y

history starts Feb 2025

Combined rank
—
EPS acceleration
—
ROE
—
MGNX NASDAQ

MACROGENICS INC

2.40 -86.36% 5Y

history starts Nov 2021

Combined rank
—
EPS acceleration
—
ROE
-34.0%
MGRX NASDAQ

MANGOCEUTICALS, INC.

0.23 -98.65% 5Y

history starts Mar 2023

Combined rank
—
EPS acceleration
—
ROE
-120.6%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.